Anapsique what it is, what is the use and side effects

Anapsique what it is, what is the use and side effects

Medical and/or psychiatric treatment of mental disorders requires, among other intervention strategies, drug administration. At this time there is a wide variety of psychotropic drugs in the market and although each laboratory markets its medications under its own commercial name, the truth is that behind these there is an active substance that acts on the symptoms.

Beyond the effect that psychopharmaceuticals have on mental health, these can be used for other purposes to treat alterations of different nature. In the following psychology-online article we focus on one of these drugs, specifically on What is Anapsique, what is the use and side effects.

You may also be interested: Paroxetine: What is it, what is the use and side effects index
  1. What is Anapsique
  2. What is Anapsique for
  3. Anapsique side effects

What is Anapsique

Anapsique is a Antidepressant drug of the Psychopharma Laboratory, S.TO. marketed in Mexico. Its administration is carried out by oral intake of the tablets. The two versions that appear in the Vademecum (2019b)[1] They differ by the dose of such tablets, there are 25mg tablets and 50mg tablets.

Anapsique active substance

Anapsique's active substance is the amitriptyin, a tricyclic antidepressant, such as imipramine and nortriptyin, and analgesic.

Amitriptyline avoids serotonin and noreprenaline reuptake, which extends its activity and enhancing its action. All this is associated with a decrease in depressive symptomatology, So tricyclic antidepressants have a great effect on the depressed population and lack effect on the population that does not present this type of symptomatology.

In addition, tricyclic antidepressants act on muscarinic histamine and acetylcholinic receptors and have blocking effects on sodium, potassium and NMDA ion channels, at the central level as a core as a core.

Anapsique contraindications

All pharmacological treatment must be subject to the supervision of a doctor, since medicines have Restrictions for certain populations. In the case at hand, Anapsique treatment is contraindicated in cases of:

  • Hypersensitivity to amitriptyline.
  • Recent myocardium infarction, heart block, heart rhythm disorders and coronary arterial insufficiency.
  • Severe hepatopathy.
  • Children under six years old.
  • In cases where the patient is being treated with monoamineoxidase (IMAO) inhibitors, since there is interaction between both drugs.

On the other hand, Anapsique It is not recommended for intake during pregnancy, However, it will be the doctor who assesses if his intake during pregnancy is extremely necessary. In the same way, as amitriptyline is present in breast milk, the doctor must assess the intake of the drug during the breastfeeding period.

Finally, since amitriptyline can produce sedation and dizziness, we must consider carrying certain activities for which it is necessary to have a good level of alert and/or that can be dangerous, such as, for example, conduct.

What is Anapsique for

As we have already mentioned, Anapsique's active substance is amitriptyline, an antidepressant and analgesic drug. Therefore, the main function of this medicine will be aimed at Treatment of depressive episodes and reduction of the sensation of pain.

Next, we will show you the indications that the Vademecum (2019a) proposes what Anapsique or amitriptyline is for. It should be taken into account that they are general indications and that, far from practicing drug administration, the treatment must always be indicated, scheduled and supervised by a health professional.

Antidepressant

The treatment of depressive disorders includes and combines psychological therapy and pharmacological therapy. Within the latter, the drugs of choice are antidepressants.

Depressive disorders constitute well -studied diagnostic categories in scientific literature. As such, they have explanatory models about their origin. While it is true that there are models proposed by different disciplines such as psychology, in the case we will pay special attention to the biological theories.

Within biological theories, the monoaminergic hypothesis of depression establishes that they exist deficits in biogenic monoamines (noreprenaline, serotonin and dopamine) among the depressed population. Therefore, drugs such as amitriptyline will be those indicated for the pharmacological treatment of depression.

Among the disorders for which anapsique administration is indicated can be the major depressive disorder and depressive episodes of bipolar disorders.

Treatment of depressive disorders with amitriptyline

The therapeutic recommendations offered by Vademecum (2019a)[2] Regarding amitriptyline they would be:

  • An initial dose of 25mg every 12 hours, being able to increase by 25mg in alternate days but always up to a maximum of 150mg per day in two shots.
  • The maintenance dose will be the same as the lowest effective dose.
  • The effect will be established after two to four weeks.
  • Treatment is usually maintained up to six months after recovery.

Analgesic

Regarding pain treatment, its neuropathic pain administration will be recommended for the prophylactic treatment of chronic tension -type headache and migraine's prophylactic treatment. The indications of the Vademecum (2019) of the use of anapsique as analgesic are:

  • The initial dose will be about 10-25mg every night, being able to increase by 10mg or 25mg every 3-7 days.
  • The analgesic effect is observed after 2-4 weeks.

Treatment for enuresis

Amitriptyline is also recommended for the treatment of night enuresis in children:

  • A 10-20mg dose is indicated every day for children from 6 to 10 years and 25-50mg every day for children 11 years or more.
  • The maximum treatment duration should not exceed 3 months.
  • The withdrawal of the drug must be gradual.

Anapsique side effects

Amitriptyline and, specifically Anapsique, has beneficial effects within the framework of the treatment for which it is indicated. However, like all drugs, it has side effects.

As adverse reactions, the Vademecum (2019b) proposes a list of symptoms that may be present to a greater or lesser extent. It is important to keep in mind that not all these symptoms will appear in all patients and, if they do, it will not be in the same way in each of them. Next, we will see the side effects of Anapsique:

  • Aggressiveness.
  • State of confusion.
  • Decreased libido.
  • Agitation.
  • Drowsiness.
  • Shaking.
  • Dizziness.
  • Headache.
  • Lethargy.
  • Speech disorder (dysarthria).
  • Attention alterations.
  • Dysgeusia.
  • Paresthesia.
  • Ataxia.
  • Accommodation alterations.
  • Mydriasis.
  • Palpitations.
  • Tachycardia.
  • Autrioventricular block.
  • Branch block.
  • Orthostatic hypotension.
  • Nasal congestion.
  • Dry Boca.
  • Constipation.
  • Nausea.
  • Hyperhidrosis.
  • Urinary disorders.
  • Urinary retention.
  • Erectile dysfunction.
  • Fatigue.
  • Thirst feeling.
  • Weight gain.
  • Anomalies in the electrocardiogram.
  • Dry eyes.
  • Alucinations can rarely occur.

This article is merely informative, in psychology-online we have no power to make a diagnosis or recommend a treatment. We invite you to go to a psychologist to treat your particular case.

If you want to read more articles similar to Anapsique: What is it, what is the use and side effects, We recommend that you enter our category of Psychopharmaceuticals.

References
  1. Vademecum (2019b) Anapsique. Recovered from https: // www.Vademecum.is/equivalence-lista-anapsique+tablets+25+mg-mexico-n06aa09-1093098-mx_1
  2. Vademecum (2019a) Amitriptyin. Recovered from https: // www.Vademecum.It is/Active-amitriptylin-N06AA09-ES